We are a biotechnology company based in Philadelphia, providing a wide range of human organ tissue blocks — including both fresh and FFPE samples — to support cross-reactivity studies for preclinical drug development.

Building on this foundation, we also develop highly active human microsomes, including liver, kidney, and intestinal microsomes, to advance drug metabolism and pharmacokinetic research.

In addition, we offer a comprehensive portfolio of primary human cells from various tissues, as well as decellularized extracellular matrix (dECM) derived from multiple human organs.

We are also actively developing a diverse array of tissue-specific organoids, aimed at enabling next-generation drug screening and advancing personalized medicine applications for human healthcare.

Our products and services provide exceptional research support with a strong commitment to excellence and precision. Backed by a team of highly qualified professionals, we not only offer standard products but also deliver personalized solutions tailored to meet each individual's unique research needs. Trust our expertise to accelerate your research, achieve outstanding results, and drive your success.